XML 22 R26.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Narrative) (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Jan. 22, 2020
shares
Dec. 24, 2019
USD ($)
$ / shares
shares
May 07, 2019
USD ($)
$ / shares
shares
May 03, 2019
USD ($)
shares
Dec. 12, 2018
USD ($)
shares
Oct. 02, 2018
Mar. 31, 2020
USD ($)
shares
Mar. 31, 2019
USD ($)
Dec. 31, 2019
shares
Subsidiary, Sale of Stock [Line Items]                  
Total common shares reserved for future issuance (in shares)             85,216,000    
Warrants Exercised             0    
Reverse stock split ratio           0.0833      
Stock-based compensation expenses | $             $ 823 $ 959  
Private Placement                  
Subsidiary, Sale of Stock [Line Items]                  
Share sold (in shares)       9,730,534          
Warrants callable     9,730,534            
Sale of stock price (usd per share) | $ / shares     $ 1.205            
Consideration received | $       $ 16,700          
Convertible Preferred stock into common stock     10            
Warrant exercise period       5 years          
Warrant exercise price (usd per share) | $ / shares     $ 1.08            
Milestone Closing                  
Subsidiary, Sale of Stock [Line Items]                  
Consideration received | $   $ 24,600              
At The Moment                  
Subsidiary, Sale of Stock [Line Items]                  
Share sold (in shares)         1,903,880        
Consideration received | $         $ 2,100        
Commission fee rate         3.00%        
Commissions paid | $         $ 100        
Shares issued (in shares)                 0
Preferred Class A | Private Placement                  
Subsidiary, Sale of Stock [Line Items]                  
Warrants callable     4,158,980            
Sale of stock price (usd per share) | $ / shares     $ 10.80            
Nonvoting convertible preferred stock issued     415,898            
Class A-2 Convertible Preferred Stock                  
Subsidiary, Sale of Stock [Line Items]                  
Convertible Preferred stock into common stock             656,682    
Reverse stock split ratio   10              
Class A-2 Convertible Preferred Stock | Milestone Closing                  
Subsidiary, Sale of Stock [Line Items]                  
Share sold (in shares)   3,288,390              
Warrants callable   32,883,900              
Consideration received | $   $ 26,000              
Warrant exercise price (usd per share) | $ / shares   $ 0.666              
Warrants, term   5 years              
Class A-1 Convertible Preferred Stock                  
Subsidiary, Sale of Stock [Line Items]                  
Convertible Preferred stock into common stock             0    
Warrant | Preferred Class A | Private Placement                  
Subsidiary, Sale of Stock [Line Items]                  
Sale of stock price (usd per share) | $ / shares     $ 0.125            
Common stock                  
Subsidiary, Sale of Stock [Line Items]                  
Conversions of convertible preferred stock (in shares)             6,566,820    
Directors, Executive Officers and Employees | Private Placement                  
Subsidiary, Sale of Stock [Line Items]                  
Share sold (in shares)       526,083          
Directors, Executive Officers and Employees | Preferred Class A | Private Placement                  
Subsidiary, Sale of Stock [Line Items]                  
Warrants callable     526,083            
Proceeds from issuance of right to purchase common shares | $     $ 600            
Certain Directors and Executive Officers [Member] | Class A-2 Convertible Preferred Stock | Milestone Closing                  
Subsidiary, Sale of Stock [Line Items]                  
Share sold (in shares)   121,581              
Warrants callable   1,215,810              
Consideration received | $   $ 1,000              
2019 Plan                  
Subsidiary, Sale of Stock [Line Items]                  
Number of additional shares authorized (in shares) 4,166,860                
Number of additional shares authorized yearly increase (in shares) 5.00%                
Common stock available for future grant (in shares)             1,571,199    
Total common shares reserved for future issuance (in shares)             1,762,220